Tech Company M&A Transactions
Axion BioSystems Acquisition
Axion BioSystems was purchased by Summa Equity. The transaction was announced on 7/16/2021. No transaction price was disclosed.
Transaction Overview
Company Name
Acquired By
Announced On
7/16/2021
Transaction Type
M&A
Amount
Unknown
M&A Terms
Summa Equity Fund II has acquired a majority stake in Axion BioSystems, a leading provider of MEA and impedance technology for single-cell analysis.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1819 Peachtree Rd. Northeast 350
Atlanta, GA 30309
USA
Atlanta, GA 30309
USA
Phone
Website
Email Address
Overview
Axion Biosystems is a life science company developing technologies that solve problems related to human heart and brain activity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Glenn Epstein
Chief Executive Officer
Thomas O'Brien
Chief Scientific Officer
Michael Clements
Chief Technical Officer
James Ross
VP - Operations
Robert Grier
VP - Sales
James Filippini
Browse more venture capital transactions:
Prev: 7/16/2021: LearnWorlds venture capital transaction
Next: 7/16/2021: Lightyear venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs